DrugPatentWatch Database Preview
Investigational Drug Information for RRx-001
Email this page to a colleague
What is the drug development status for RRx-001?
RRx-001 is an investigational drug.
There have been 12 clinical trials for RRx-001.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 24th 2018.
The most common disease conditions in clinical trials are Carcinoma, Lung Neoplasms, and Neoplasm Metastasis. The leading clinical trial sponsors are EpicentRx, Inc., Drais Pharmaceuticals, Inc., and Prothex Pharma, Inc.
There are eight US patents protecting this investigational drug and thirty-eight international patents.
Summary for RRx-001
| US Patents | 8 |
| International Patents | 38 |
| US Patent Applications | 28 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2018-12-24) |
| Vendors | 39 |
Recent Clinical Trials for RRx-001
| Title | Sponsor | Phase |
|---|---|---|
| RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors | Texas Children's Cancer Center | Phase 1 |
| RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors | EpicentRx, Inc. | Phase 1 |
| RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer | EpicentRx, Inc. | Phase 3 |
Clinical Trial Summary for RRx-001
Top disease conditions for RRx-001
Top clinical trial sponsors for RRx-001
US Patents for RRx-001
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| RRx-001 | ⤷ Sign up for a Free Trial | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | RadioRx, Inc. (Menlo Park, CA) Alliant Techsystems Inc. (Edina, MN) | ⤷ Sign up for a Free Trial |
| RRx-001 | ⤷ Sign up for a Free Trial | Methods of synthesizing cyclic nitro compounds | Alliant Techsystems Inc. (Minneapolis, MN) | ⤷ Sign up for a Free Trial |
| RRx-001 | ⤷ Sign up for a Free Trial | Methods of synthesizing cyclic nitro compounds | Alliant Techsystems Inc. (Arlington, VA) | ⤷ Sign up for a Free Trial |
| RRx-001 | ⤷ Sign up for a Free Trial | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | RadioRx, Inc. (Menlo Park, CA) Alliant Techsystems Inc. (Minneapolis, MN) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for RRx-001
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| RRx-001 | Australia | AU2006279589 | 2025-08-12 | ⤷ Sign up for a Free Trial |
| RRx-001 | Canada | CA2620612 | 2025-08-12 | ⤷ Sign up for a Free Trial |
| RRx-001 | China | CN101370492 | 2025-08-12 | ⤷ Sign up for a Free Trial |
| RRx-001 | Cyprus | CY1116094 | 2025-08-12 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
